Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of CALGB 51101 (Alliance).

CALGB 51101 – consolidation with autoSCT vs Chemo (AraC+Etop) in PCSNL. Auto superior with mPFS of 6 yrs vs. 2.4yrs. However, more patients went off treatment in the chemo arm prior to randomization due to progression or death. #ASCO2021

Read the full article here

Related Articles